DEVELOPMENT OF A BROAD-SPECTRUM THERAPEUTIC

NIH RePORTER · NIH · N01 · $2,600,780 · view on reporter.nih.gov ↗

Abstract

To support the development of therapeutic products for use in post-event settings following the intentional release of a NIAID Category A, B, or C Priority Pathogen or in response to naturally occurring outbreaks of infectious diseases caused by these pathogens; includes the conduct of a Phase I clinical trial.

Key facts

NIH application ID: 10551007
Project number: 272201600028C-P00015-9999-1
Recipient: ABVIRO, LLC
Principal Investigator: URBAN RAMSTEDT
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $2,600,780
Award type: —
Project period: 2016-09-23 → 2022-06-25